DTIL logo

Precision BioSciences, Inc.

DTIL
Healthcare|Biotechnology|US
$10.60
+0.73 (+7.40%)
Tangible Book / Share
$1.85
Cash / Share
$2.98

Ownership Breakdown

93.4%
Float
27.6M
Shares Outstanding
25.8M
Float Shares

Major Holders (26)

Combined: 170.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Matthew SmithIndividual9.40%1,119,311Aug 14, 202513D/G
Readout Capital, LPPartnership9.30%1,106,437Aug 14, 202513D/G
Readout Capital GP, LLCOther9.30%1,106,437Aug 14, 202513D/G
abrdn Inc.IA, CO8.88%2,138,603Jan 27, 202613D/G
Aberdeen Group plcHolding company8.88%2,138,603Jan 27, 202613D/G
Janus Henderson Biotech Innovation Master Fund LtdInvestment company8.70%628,126Nov 14, 202413D/G
Bleichroeder LPInvestment adviser8.21%1,900,000Feb 13, 202613D/G
Bleichroeder Holdings LLCHolding company8.21%1,900,000Feb 13, 202613D/G
Andrew GundlachHolding company8.21%1,900,000Feb 13, 202613D/G
ROC Holdings SPV II, LPPartnership7.60%906,437Aug 14, 202513D/G
Readout Holdings GP, LLCOther7.60%906,437Aug 14, 202513D/G
Perceptive Advisors LLCInvestment adviser5.90%426,293Nov 14, 202413D/G
Perceptive Life Sciences Master Fund, Ltd.Corporation5.90%426,293Nov 14, 202413D/G
Joseph EdelmanIndividual5.90%426,293Nov 14, 202413D/G
Octagon Capital Advisors LPIA, PN5.73%1,651,497Nov 3, 202613D/G
Ting JiaHC, IN5.73%1,651,497Nov 3, 202613D/G
Octagon Investments Master Fund LPPN, OO5.73%1,651,497Nov 3, 202613D/G
Weston NicholsIndividual5.40%1,390,611Jul 20, 202613D/G
Lynx1 Capital Management LPPartnership5.40%1,390,611Jul 20, 202613D/G
BlackRock, Inc.Holding company5.01%1,384,230Oct 27, 202613D/G
Empery Asset Management, LPIA, PN4.99%1,314,393Jul 29, 202613D/G
Ryan M. LaneHC, IN4.99%1,314,393Jul 29, 202613D/G
Weinstein BenjaminIndividual4.00%1,105,720Aug 24, 202613D/G
Novartis AGHC, CO3.70%413,581Aug 6, 202513D/G
Novartis Pharma AGCorporation3.70%413,581Aug 6, 202513D/G
Highbridge Capital Management, LLCIA, OO3.70%406,250Apr 25, 202513D/G

Insider Trades (100)

Last 4 quarters: 579,537 acquired · 575,818 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Frankel StanleydirectorSep 28, 2026BUY1,000$6.00$6.0KForm 4
Brown MelindadirectorSep 25, 2026BUY1,135$6.27$7.1KForm 4
Germano Geno JdirectorSep 25, 2026BUY2,609$6.28$16.4KForm 4
Gorsuch Cassandra LouiseChief Scientific OfficerAug 1, 2026OTHER0——Form 4
Gorsuch Cassandra LouiseChief Scientific OfficerAug 1, 2026OTHER235$36.00$8.5KForm 4
Gorsuch Cassandra LouiseChief Scientific OfficerAug 1, 2026OTHER585$359.40$210.2KForm 4
Gorsuch Cassandra LouiseChief Scientific OfficerAug 1, 2026OTHER179,340——Form 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER0——Form 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER945$378.00$357.2KForm 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER214$174.90$37.4KForm 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER403$340.20$137.1KForm 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER778$122.40$95.2KForm 4
Burris Mei Zhang LuChielf Accounting OfficerAug 1, 2026OTHER30,129——Form 4
Tanna Naresh HareshChief Financial OfficerAug 1, 2026OTHER0——Form 4
Tanna Naresh HareshChief Financial OfficerAug 1, 2026OTHER179,340——Form 4
Brown MelindadirectorJun 3, 2026AWARD20,979——Form 4
Frankel StanleydirectorJun 3, 2026AWARD20,979——Form 4
Germano Geno JdirectorJun 3, 2026AWARD20,979——Form 4
Pire Shari LisadirectorJun 3, 2026AWARD20,979——Form 4
Buehler KevindirectorJun 3, 2026AWARD20,979——Form 4
Buehler KevindirectorMay 20, 2026OPTION EX.21,000——Form 4
Buehler KevindirectorMay 20, 2026OPTION EX.21,000——Form 4
Frankel StanleydirectorMay 20, 2026OPTION EX.21,000——Form 4
Frankel StanleydirectorMay 20, 2026OPTION EX.21,000——Form 4
Brown MelindadirectorMay 20, 2026OPTION EX.21,000——Form 4
Brown MelindadirectorMay 20, 2026OPTION EX.21,000——Form 4
Pire Shari LisadirectorMay 20, 2026OPTION EX.21,000——Form 4
Pire Shari LisadirectorMay 20, 2026OPTION EX.21,000——Form 4
Germano Geno JdirectorMay 20, 2026OPTION EX.21,000——Form 4
Germano Geno JdirectorMay 20, 2026OPTION EX.21,000——Form 4
Amoroso Michaeldirector, officer: President and CEOFeb 17, 2026OPTION EX.67,797——Form 4
Amoroso Michaeldirector, officer: President and CEOFeb 18, 2026SELL20,559$3.84$78.9KForm 4
Amoroso Michaeldirector, officer: President and CEOFeb 17, 2026OPTION EX.67,797——Form 4
Kelly John AlexanderChief Financial OfficerFeb 17, 2026OPTION EX.27,584——Form 4
Kelly John AlexanderChief Financial OfficerFeb 18, 2026SELL8,149$3.84$31.3KForm 4
Kelly John AlexanderChief Financial OfficerFeb 17, 2026OPTION EX.27,584——Form 4
Scimeca DarioGeneral Counsel and SecretaryFeb 17, 2026OPTION EX.16,667——Form 4
Scimeca DarioGeneral Counsel and SecretaryFeb 18, 2026SELL4,925$3.84$18.9KForm 4
Scimeca DarioGeneral Counsel and SecretaryFeb 17, 2026OPTION EX.16,667——Form 4
SMITH J. JEFFERSONChief Research OfficerFeb 17, 2026OPTION EX.16,667——Form 4
SMITH J. JEFFERSONChief Research OfficerFeb 18, 2026SELL4,925$3.84$18.9KForm 4
SMITH J. JEFFERSONChief Research OfficerFeb 17, 2026OPTION EX.16,667——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.69,421——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 22, 2026SELL34,799$4.17$145.1KForm 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.37,069——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.8,888——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.69,421——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.37,069——Form 4
Amoroso Michaeldirector, officer: President and CEOJan 20, 2026OPTION EX.8,888——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.14,908——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 21, 2026SELL8,854$4.03$35.7KForm 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.8,425——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.1,978——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.14,908——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.8,425——Form 4
Scimeca DarioGeneral Counsel and SecretaryJan 20, 2026OPTION EX.1,978——Form 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.26,575——Form 4
Kelly John AlexanderChief Financial OfficerJan 21, 2026SELL15,213$4.03$61.3KForm 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.13,900——Form 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.3,888——Form 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.26,575——Form 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.13,900——Form 4
Kelly John AlexanderChief Financial OfficerJan 20, 2026OPTION EX.3,888——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 21, 2026OPTION EX.16,219——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 21, 2026SELL10,200$4.03$41.1KForm 4
SMITH J. JEFFERSONChief Research OfficerJan 20, 2026OPTION EX.10,447——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 20, 2026OPTION EX.2,500——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 20, 2026OPTION EX.16,219——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 20, 2026OPTION EX.10,447——Form 4
SMITH J. JEFFERSONChief Research OfficerJan 20, 2026OPTION EX.2,500——Form 4
Germano Geno JdirectorDec 16, 2025BUY3,000$4.72$14.2KForm 4
Frankel StanleydirectorDec 16, 2025BUY2,700$4.70$12.7KForm 4
Brown MelindadirectorDec 15, 2025BUY1,381$4.97$6.9KForm 4
Kelly John AlexanderChief Financial OfficerNov 2, 2025OPTION EX.3,605——Form 4
Kelly John AlexanderChief Financial OfficerNov 3, 2025SELL1,303$6.49$8.5KForm 4
Kelly John AlexanderChief Financial OfficerNov 2, 2025OPTION EX.3,605——Form 4
Scimeca DarioGeneral Counsel and SecretaryNov 2, 2025OPTION EX.1,835——Form 4
Scimeca DarioGeneral Counsel and SecretaryNov 3, 2025SELL665$6.49$4.3KForm 4
Scimeca DarioGeneral Counsel and SecretaryNov 2, 2025OPTION EX.1,835——Form 4
Amoroso Michaeldirector, officer: President and CEONov 2, 2025OPTION EX.9,444——Form 4
Amoroso Michaeldirector, officer: President and CEONov 3, 2025SELL3,409$6.49$22.1KForm 4
Amoroso Michaeldirector, officer: President and CEONov 3, 2025OPTION EX.9,444——Form 4
Frankel StanleydirectorSep 26, 2025BUY2,700$4.97$13.4KForm 4
Brown MelindadirectorSep 22, 2025BUY1,400$4.89$6.8KForm 4
Kelly John AlexanderChief Financial OfficerJul 3, 2025SELL14,827$4.26$63.2KForm 4
Brown MelindadirectorJun 25, 2025BUY1,682$4.14$7.0KForm 4
Buehler KevindirectorJun 25, 2025BUY5,076$4.16$21.1KForm 4
Germano Geno JdirectorJun 3, 2025AWARD21,000——Form 4
Germano Geno JdirectorMay 27, 2025OPTION EX.9,826——Form 4
Germano Geno JdirectorMay 27, 2025OPTION EX.9,826——Form 4
Pire Shari LisadirectorJun 3, 2025AWARD21,000——Form 4
Pire Shari LisadirectorMay 27, 2025OPTION EX.9,826——Form 4
Pire Shari LisadirectorMay 27, 2025OPTION EX.9,826——Form 4
Frankel StanleydirectorJun 3, 2025AWARD21,000——Form 4
Frankel StanleydirectorMay 27, 2025OPTION EX.9,826——Form 4
Frankel StanleydirectorMay 27, 2025OPTION EX.9,826——Form 4
Buehler KevindirectorMay 27, 2025OPTION EX.9,826——Form 4
Buehler KevindirectorJun 3, 2025AWARD21,000——Form 4
Buehler KevindirectorMay 27, 2025OPTION EX.9,826——Form 4
Brown MelindadirectorJun 3, 2025AWARD21,000——Form 4